What Cannabix Technologies does

Cannabix Technologies Inc. is a Canadian micro-cap public company (CSE: BLO; OTC: BLOZF; FWB: 8CT), headquartered in Burnaby, British Columbia, that develops non-invasive breath testing technologies for the detection of recent cannabis (THC) and alcohol use. Its core technology combines a proprietary Breath Collection Unit (BCU) — which captures breath samples in the field — with laboratory confirmation via Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS), delivered in partnership with Omega Laboratories Inc. The system is positioned around a roughly four-hour detection window that aligns with impairment rather than historical exposure, addressing limitations of urine-based testing. Supporting technologies include FAIMS-based field screening (Field Asymmetric Ion Mobility Spectrometry), a THC Breath Analyzer (THCBA) point-of-care device developed through version 4.0, and a contactless Contactless Alcohol Breathalyzer (CAB) for workplace and in-vehicle deployment.

The company's commercial product portfolio centers on the Marijuana Breath Test (MBT) system (BCU plus proprietary Breath Cartridges) for law enforcement and workplace safety buyers, and the BreathLogix automated alcohol screening platform sold primarily through exclusive distribution partners in Australia (Breathalyser Sales & Service Pty Ltd) and Quebec (Alco Prevention Canada), with direct enterprise field sales in the rest of North America. Pricing is quote-based with multi-year contract cadence; no standard pricing is published. Revenue mechanics blend one-time hardware sales, recurring consumables (breath cartridges), and partner-delivered laboratory analysis services. The primary customer segments are law enforcement and government agencies (police departments, district attorneys' offices, criminalistics laboratories) and workplace safety buyers in mining, construction, municipal services, aviation, oil and gas, and heavy materials — with clinical validation partners providing research support. Cannabix holds granted US and Canadian patents on its cannabis detection devices and FAIMS technology, has filed PCT applications for breath capture and contactless analysis, and in May 2026 secured UL and CSA electrical safety certifications for the BCU, enabling formal government and enterprise procurement participation.

Name

Cannabix Technologies

Legal name

Cannabix Technologies Inc.

Website

https://cannabixtechnologies.com

Company type

Public

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Short description

Cannabix Technologies (CSE: BLO) develops non-invasive breath testing devices that detect recent cannabis (THC) and alcohol use, combining a proprietary Breath Collection Unit with LC-MS/MS laboratory confirmation. It sells the Marijuana Breath Test system to law enforcement and the BreathLogix alcohol platform to workplace safety buyers across North America and Australia.

Ownership category

akta.pro rank

Product category

Breath Analysis and Drug Testing Devices

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Testing Laboratories and Services (541380)

SIC

Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734)

akta.pro primary industry

Test & Measurement Equipment (Oscilloscopes, DAQ, signal analyzers, calibration benches) (IMAGAFAC)

akta.pro secondary industry

Bioanalytical Testing (PK/ADA/NAb) (HLAGADAA)

Keywords

• Breath analysis technology
• THC detection devices
• Alcohol screening systems
• Workplace drug testing
• Law enforcement breathalyzers

Headquarters

HQ city

Burnaby

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Breath Collection Unit (BCU) Hardware Sales: Sale of the proprietary Breath Collection Unit (BCU) hardware device to law enforcement agencies, workplaces, and government entities. This is a one-time capital equipment sale model. Units are deployed in the field and used to collect breath samples for transport to partner laboratories for analysis.
2. BreathLogix Device and Consumables: Sale of BreathLogix branded devices (via exclusive Australian distribution partner Breathalyser Sales & Service) and associated consumables (breath collection cartridges/media). The consumables represent a recurring consumables revenue stream tied to the volume of tests conducted.
3. Laboratory Analysis Services (via Omega Partnership): Laboratory confirmation services using LC-MS/MS, conducted by partner Omega Laboratories Inc. Revenue from these services flows through the strategic partnership as part of the phased commercialization model. Omega performs the analytical testing on breath samples collected by the BCU hardware.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

Cannabix Technologies develops and manufactures non-invasive breath testing hardware systems for detecting recent cannabis (THC) and alcohol use. Its core offerings are the Cannabix Marijuana Breath Test (MBT) — using the Breath Collection Unit (BCU) and proprietary cartridges coupled with LC-MS laboratory confirmation — and the BreathLogix automated, contactless alcohol breathalyzer with its BreathLogixConnect data management platform. The products are sold to law enforcement agencies, government bodies, and employers in safety-sensitive industries.

Product overview

Cannabix Technologies offers a portfolio of breath testing products for detecting THC (marijuana) and alcohol. The core offerings include the Cannabix Marijuana Breath Test (MBT) system consisting of the Breath Collection Unit and Breath Cartridges for delta-9 THC detection, and the BreathLogix alcohol screening platform with wall-mounted contactless devices. Supporting products include the BreathLogixConnect data management platform, THC Breath Analyzer (THCBA) for point-of-care screening, and laboratory equipment including the MS Breath Sampler (MSBS) for mass spectrometry confirmation. The company also developed FAIMS technology for portable THC detection and Contactless Alcohol Breathalyzer (CAB) devices for workplace and vehicle applications.

Differentiator

Problem solved

Functional benefit

Brands

• BreathLogix: Automated alcohol screening technology platform for workplace safety including contactless breath alcohol testing devices
• BreathLogixConnect
• Marijuana Breath Test (MBT)
• Breath Collection Unit (BCU)

Products and services

• Cannabix Marijuana Breath Test (MBT) Non-invasive breath testing system that detects delta-9 THC in breath within approximately 2-4 hours of cannabis consumption, designed for workplace safety and law enforcement applications. Uses the proprietary Breath Collection Unit (BCU) and Breath Cartridges with LC-MS/MS laboratory confirmation.
• BreathLogix Alcohol Breathalyzer Fully automated, contactless breath alcohol screening system for workplace settings. Provides rapid, unmanned alcohol testing with photo capture, real-time alerts, and integration with the BreathLogixConnect data management platform. Approved by the U.S. National Highway Traffic Safety Administration.
• BreathLogixConnect Cloud-based data management platform for BreathLogix devices that provides testing data access, reports, graphs, summaries, and automated alert notifications, leveraging AWS infrastructure for security and identity management.
• Breath Collection Unit (BCU) Portable handheld device that collects breath samples for laboratory analysis. Core hardware component of the MBT system that captures exhaled breath for delta-9 THC detection, certified to UL 61010-1 and CSA 61010-1-12 standards.
• THC Breath Analyzer (THCBA) Drug screening device designed for point-of-care detection of delta-9 THC in breath, providing results in under five minutes. Multiple versions developed with machine learning database training for improved sensitivity ranges.
• Contactless Alcohol Breathalyzer (CAB) Wall-mounted and in-vehicle breath alcohol detection device that operates in contactless mode without mouthpieces or straws. Designed for workplace pre-access testing and vehicle integration, featuring photo identity confirmation and real-time BAC results.
• MS Breath Sampler (MSBS) Laboratory-based mass spectrometer front-end hardware that analyzes breath samples collected by the BCU. Utilizes liquid secondary adsorption technique for efficient THC detection with results in under 2 minutes without sample preparation.
• Breath Cartridges Proprietary single-use breath collection cartridges used with the Breath Collection Unit to capture and preserve breath samples for LC-MS laboratory analysis, representing a recurring consumables revenue stream.
• FAIMS Detection Unit Field asymmetric waveform ion mobility spectrometry technology for detection of non-volatile compounds like THC in breath. Uses ion mobility filtering techniques related to mass spectrometry for portable drug detection.

Quantifiable outcome

• ~4-hour detection window correlates with impairment rather than historical use (vs. 30+ days for urine-based THC testing)
• +4 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

Eight partnerships are on record, tiered flagship, core and minor.

• Omega Laboratories Inc.flagshipStrategic or Co-development PartnerOmega Laboratories Inc. is the primary strategic and co-development partner for Cannabix's Marijuana Breath Tester (MBT) system. The partnership operates on a phased commercialization model spanning more than 20 months of collaboration. Under the agreement, Cannabix supplies the Breath Collection Unit (BCU) hardware and Omega Laboratories provides LC-MS/MS laboratory confirmation analysis services. Together, the two companies form an end-to-end solution for court-admissible cannabis breath testing. The partnership also involves regulatory engagement with Health Canada as part of the commercialization pathway.
• Breathalyser Sales & Service Pty LtdcoreChannel Partner/ Reseller/ DistributorBreathalyser Sales & Service Pty Ltd is the exclusive distribution partner for the BreathLogix system in Australia. The partner covers all aspects of sales, distribution, service, and customer support for mining, municipal, and aviation workplace safety customers across Australia. This exclusive arrangement provides Cannabix with immediate market access to the Australian workplace safety sector without requiring direct local entity establishment.
• Alco Prevention CanadacoreChannel Partner/ Reseller/ DistributorAlco Prevention Canada serves as a regional distributor for Cannabix's products in the province of Quebec. Alco Prevention Canada handles local sales, deployment, and customer support for the Quebec market, complementing Cannabix's direct sales operations in the rest of Canada.
• North Louisiana Criminalistics LaboratoryminorImplementation/ SI/ Consulting PartnerNorth Louisiana Criminalistics Laboratory served as a testing and validation host for the MBT system. The laboratory provided the controlled environment necessary to process and analyze breath samples collected during the technology development and validation phase.
• Friedel ClinicminorImplementation/ SI/ Consulting PartnerFriedel Clinic, a Montana-based medical and clinical research organization, conducted clinical testing and data collection for the MBT / THC breath analysis technology as part of the research validation process. The clinic provided access to human subjects and clinical expertise for the validation studies.
• Montgomery County Police DepartmentminorImplementation/ SI/ Consulting PartnerThe Montgomery County Police Department participated in field testing and validation of the MBT system in a real-world law enforcement setting. The agency's involvement provided practical feedback on field deployment usability and generated real-world validation data.
• Warren County, Pennsylvania District Attorney's OfficeminorImplementation/ SI/ Consulting PartnerThe Warren County, PA District Attorney's Office participated in a pilot program for the MBT system, evaluating its suitability as evidence in cannabis-related prosecutions. The pilot provided feedback on court-admissibility and operational integration with prosecutorial workflows.
• Audacia BioscienceminorStrategic or Co-development PartnerAudacia Bioscience, led by Dr. Phillip Olla, conducted independent research and THC breath analysis validation studies for Cannabix Technologies. The independent scientific validation by Audacia strengthens the credibility of the technology's detection accuracy and supports regulatory and legal acceptance of the system.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Hound Labs: Developer of the HOUND MARIJUANA BREATHALYZER, the most direct competitor to Cannabix's MBT system. Both companies target the same breath-based THC detection opportunity for law enforcement and workplace safety, with Hound Labs having achieved earlier commercialization and law enforcement partnerships.
• Lifeloc Technologies: US-based manufacturer of professional breath alcohol testing devices (LifeLoc FC Series) for law enforcement, workplace, and corrections markets. Comparable in the breath-based testing device category and customer base, though Lifeloc currently focuses on alcohol rather than THC detection.
• Intoximeters: Manufacturer of evidential breath alcohol testing instruments (Intoxilyzer) widely used by US law enforcement. Comparable as a breath-testing device maker serving law enforcement, with deep customer relationships in the impairment testing market that Cannabix also targets.
• CMI Inc. Manufacturer of intoxilyzer breath alcohol testing equipment for law enforcement and corrections. Comparable as a specialized breath-testing device vendor with overlapping law enforcement and workplace safety customers, though Cannabix's focus on cannabis detection differentiates the technology offering.

Broad incumbents

• Dräger: German industrial safety and medical technology company with a broad breath alcohol and drug detection product portfolio (Dräger Alcotest). Comparable in workplace and law enforcement breath testing but does not currently offer a commercial breath-based THC detection system at Cannabix's level of specificity.
• Thermo Fisher Scientific: Global leader in analytical instruments, including the mass spectrometry and LC-MS/MS systems used by partner Omega Laboratories for THC confirmation. Comparable as a provider of the underlying laboratory analytical instrument technology central to Cannabix's MBT confirmation workflow.
• Quest Diagnostics: Major clinical laboratory services company providing workplace drug testing, including urine-based cannabis screening. Comparable as a participant in the workplace drug testing market that Cannabix targets, though Quest's primary modality (urine) lacks the recent-use detection window of Cannabix's breath-based approach.
• Agilent Technologies: Major manufacturer of analytical laboratory instruments including mass spectrometers and chromatography systems. Comparable as a provider of analytical measurement technology used in laboratory-based confirmation of substances, an essential element of Cannabix's MBT solution.
• SCIEX: Specialized provider of mass spectrometry and LC-MS/MS instruments widely used in forensic and clinical laboratories. Comparable in providing the laboratory analytical instrumentation that underpins the confirmation workflow for cannabis and other substance testing.

Others

• Omega Laboratories: Cannabix's flagship strategic partner and an international leader in forensic drugs of abuse testing for over 25 years. Bill Corl, CEO of Omega Laboratories, also sits on Cannabix's board. Comparable as a laboratory services provider in the cannabis testing space, though operating as a partner rather than a competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cannabix-technologies-inc
• Xx.com/Cannabix_BLO

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cannabix Technologies